PubMed · 4556905
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
R A Good. 1972-08-10. Lymphocyte surface markers.. https://doi.org/10.1056/nejm197208102870614
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
This manuscript describes a support vector machine based method for the prediction of constitutive as well as immunoproteasome cleavage sites in antigenic sequences. This method achieved Matthew's correlation coefficents of 0.54 and 0.43 on in vitro and major histocompatibility complex ligand data, respectively. This shows that the performance of our method is comparable to that of the NetChop method, which is currently considered to be the best method for proteasome cleavage site prediction. Based on the method, a web server, Pcleavage, has also been developed. This server accepts protein sequences in any standard format and present results in a user-friendly format. The server is available for free use by all academic users at the URL http://www.imtech.res.in/raghava/pcleavage/ or http://bioinformatics.uams.edu/mirror/pcleavage/.
Explore the source record for details and available documents.
A better understanding of the molecules involved in immune responses has identified many potential targets for the treatment of autoimmune diseases. But although successful therapies have been found for immune disorders in animal studies, few have passed the much harder test of treating human diseases. So far, non-antigen-specific approaches, such as the blocking of tumour-necrosis factor, are achieving some success but the same is not true for antigen-specific approaches. Future therapies will probably include both non-antigen-specific strategies that target cytokines (cell-cell signalling molecules) or block the molecules that stimulate immune responses, and antigen-specific therapies that induce tolerance to self antigens.